Alterations of bone metabolism of patients with primary and platinum-sensitive recurrent tuboovarian carcinoma induced by platinum-based chemotherapy with and without bevacizumab

被引：0
|
作者：
Kurbacher, C. M. [1 ]
Herz, S. [1 ]
Kurbacher, A. T. [1 ]
Rhau, W. [1 ]
Kurbacher, J. A. [1 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Bonn, Germany
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1247
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [21] Outcome of Recurrent Uterine Papillary Serous Carcinoma Treated With Platinum-Based Chemotherapy
    Mahdi, Haider
    Rizzo, Anthony
    Rose, Peter G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (03) : 467 - 473
  • [22] Olaparib maintenance therapy in patients (pts) with platinum-sensitive relapsed (PSR) ovarian cancer (OC) and stable disease (SD) following platinum-based chemotherapy
    Oza, A. M.
    Cibula, D.
    Oaknin, A.
    Poole, C.
    Mathijssen, R. H. J.
    Sonke, G. S.
    Colombo, N.
    Spacek, J.
    Vuylsteke, P.
    Hirte, H.
    Pfisterer, J.
    Plante, M.
    Hanker, L. C.
    Fielding, A.
    Haddad, V.
    Chmielecki, J.
    Friedlander, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 340 - 340
  • [23] OUTCOMES OF PLATINUM-SENSITIVE SMALL CELL LUNG CANCER (SCLC) PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY RECHALLENGE: A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS
    Genestreti, G.
    Metro, G.
    Kenmotsu, H.
    Carloni, F.
    Burgio, M. A.
    Casanova, C.
    Tiseo, M.
    Scarpi, E.
    Korkmaz, T.
    Califano, R.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S28 - S28
  • [24] Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study
    Valenza, Carmine
    Mongillo, Marta
    Boldrini, Laura
    Guidi, Lorenzo
    Farfalla, Alessia
    Malengo, Daniela
    Caruso, Giuseppe
    Lapresa, Mariateresa
    Parma, Gabriella
    Biagioli, Elena
    Curigliano, Giuseppe
    Colombo, Nicoletta
    Visconti, Maria Vittoria
    Katrini, Jalissa
    Trapani, Dario
    Derio, Silvia
    GYNECOLOGIC ONCOLOGY, 2025, 194 : 11 - 17
  • [25] A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.
    Liu, Joyce F.
    Brady, Mark F.
    Matulonis, Ursula A.
    Miller, Austin
    Kohn, Elise C.
    Swisher, Elizabeth M.
    Tew, William P.
    Cloven, Noelle Gillette
    Muller, Carolyn
    Bender, David
    Moore, Richard G.
    Michelin, David Paul
    Waggoner, Steven E.
    Geller, Melissa Ann
    Fujiwara, Keiichi
    D'Andre, Stacy D.
    Carney, Michael
    Secord, Angeles Alvarez
    Moxley, Katherine M.
    Bookman, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer
    Case, Ashley S.
    Rocconi, Rodney P.
    Partridge, Edward E.
    Straughn, J. Michael, Jr.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (01) : 223 - 227
  • [27] Phase I trial of ribociclib (LEE-011) with platinum-based chemotherapy in recurrent platinum sensitive ovarian cancer
    Coffman, Lan
    Orellana, Taylor
    Normolle, Daniel
    Courtney-Brooks, Madeleine
    Boisen, Michelle
    Olawaiye, Alexander
    Berger, Jessica
    Lesnock, Jamie
    Sukumvanich, Paniti
    Taylor, Sarah
    McLean, Karen
    Uppal, Shitanshu
    Buckanovich, Ronald
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S69 - S69
  • [28] Effect of prior olaparib maintenance therapy for platinum sensitive recurrent ovarian cancer on response to subsequent platinum-based chemotherapy
    Nakazawa, Hiroshi
    Nagao, Shoji
    Narita, Moyu
    Shibutani, Takashi
    Jimi, Tomoatsu
    Yano, Hiroko
    Kitai, Miho
    Shiozaki, Takaya
    Yamaguchi, Satoshi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (05) : 1248 - 1254
  • [29] Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial
    Yang, Jiaxin
    Wu, Xiaohua
    Zhu, Jianqing
    Song, Liang
    Feng, Yanling
    Wang, Jing
    Wu, Lingying
    Liu, Ziling
    Gao, Yunong
    Wang, Danbo
    Lou, Ge
    Yang, Hongying
    Zhou, Qi
    Kong, Beihua
    Huang, Yi
    Chen, Lipai
    Li, Guiling
    An, Ruifang
    Wang, Ke
    Zhang, Yu
    Yan, Xiaojian
    Lu, Xin
    Wang, Li
    Tan, Tao
    Dong, Juan
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S18 - S18
  • [30] A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
    Chua, DTT
    Sham, JST
    Au, GKH
    ORAL ONCOLOGY, 2003, 39 (04) : 361 - 366
12345